Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
October 25, 2025 11:01 ET | Source: Cullinan Therapeutics, Inc. CLN-978 led…
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $345 Million
SAN FRANCISCO and BOSTON, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics,…
Idorsia successfully completes an upsized offering of shares funding the company to overall profitability
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION,…
Ipsen – September 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares…
Nexteer Showcases Motion-by-Wire Innovations & Shares Insights on Software-Defined Vehicles at MOVE America
Steer-by-Wire, Rear-Wheel Steering, Brake-by-Wire, Software & More in Detroit September 24-25 DETROIT,…
DAR GLOBAL BECOMES FIRST SAUDI COMPANY TO TRANSFER TO EQUITY SHARES IN COMMERCIAL COMPANIES CATEGORY ON THE LONDON STOCK EXCHANGE
LONDON and JEDDAH, Saudi Arabia, Sept. 10, 2025 /PRNewswire/ -- Dar Global PLC,…
Huawei Shares Industrial Challenges at the 2025 ICPC World Finals
BAKU, Azerbaijan, Sept. 10, 2025 /PRNewswire/ -- The St. Petersburg State University team…
NYSE Content Advisory: Pre-Market Update + Alphabet shares pop 7% to lift S&P 500
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- The New York Stock Exchange…
IMG Shares 2025 Autumn Travel Trends: Top Destinations and Increased Spending
IMG took a sample of its customers and reviewed more than 30,000…
Voting Rights and Shares Capital of the Company
In accordance with articles L.233-8 II of the French Commercial Code and…
